Copyright
©The Author(s) 2004.
World J Gastroenterol. Apr 1, 2004; 10(7): 1032-1036
Published online Apr 1, 2004. doi: 10.3748/wjg.v10.i7.1032
Published online Apr 1, 2004. doi: 10.3748/wjg.v10.i7.1032
Table 1 Effect of BPC 157 on indomethacin induced gastric ulcer formation (n = 10)
| Administration | Agents | Dosage (ng/kg) | Ulcer (mm2) | Inhibition ratio(%) |
| im | Saline control | 19.22 ± 2.95 | ||
| Excipient control | 20.90 ± 7.55 | |||
| Famotidine | 40 000 | 8.20 ± 4.68 | 60.8b | |
| BPC 157 | 200 | 9.71 ± 5.00 | 53.5b | |
| BPC 157 | 400 | 7.22 ± 4.01 | 65.5b | |
| BPC 157 | 800 | 7.22 ± 4.64 | 65.5b | |
| ig | Saline control | 20.18 ± 8.50 | ||
| Famotidine | 40 000 | 8.28 ± 3.45 | 58.9b | |
| BPC 157 | 200 | 13.56 ± 6.79 | 32.8 | |
| BPC 157 | 400 | 9.92 ± 2.62 | 50.8b | |
| BPC 157 | 800 | 9.75 ± 5.25 | 51.7b |
- Citation: Xue XC, Wu YJ, Gao MT, Li WG, Zhao N, Wang ZL, Bao CJ, Yan Z, Zhang YQ. Protective effects of pentadecapeptide BPC 157 on gastric ulcer in rats. World J Gastroenterol 2004; 10(7): 1032-1036
- URL: https://www.wjgnet.com/1007-9327/full/v10/i7/1032.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i7.1032